Strontium89 Now Reimbursed in Hospital and Outpatient Settings for Metastatic Bone Pain Treatment
Strontium89 Now Reimbursed in All Treatment Settings PR Newswire NEW YORK, Jan. 7, 2021 NEW YORK, Jan. 7, 2021 /PRNewswire/ — Q BioMed
Read more
strontium89
Q BioMed Announces Strontium89 Initial Uptake and Momentum in US and Europe
Several International Market Authorisations Expected in Q4 Expanding Access to South and Central America and Asia PR Newswire NEW YORK,
Read more
Q BioMed Announces Strontium89 will be available as of September 2020 through Named Patient Program for Bone Metastases Pain Palliation in EU and Rest of World
PR Newswire NEW YORK, Aug. 11, 2020 NEW YORK, Aug. 11, 2020 /PRNewswire/ — Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced
Read more
Q BioMed Adds to Leadership Team With Global Head of Regulatory Affairs
Initial focus on global rollout of Strontium89 PR Newswire NEW YORK, March 31, 2020 NEW YORK, March 31, 2020 /PRNewswire/ — Q BioMed
Read more